Qiming Venture's Leung on Biotech Opportunities

The video discusses the volatile investment landscape in China and globally, focusing on healthcare. Despite a decline in overall investment, early-stage deals are increasing. The video highlights IPOs in healthcare, the impact of Chinese government policies on drug pricing, and the global role of Chinese companies. It also covers portfolio strategies and the importance of innovation in drug development.

How have recent IPOs in the healthcare sector reflected the growth of companies in China?

What opportunities exist for Chinese companies in the global market for drugs and devices?

What innovations have been made in the development of vaccines in China?